Marseille E, Walker RS, Hickey MD, Grochowski J, et al. Cost-effectiveness of long-acting injectable cabotegravir-rilpivirine as HIV treatment per virally-suppressed persons in a San Francisco clinic: an intermediary outcome analysis. AIDS 2025 Feb 5. doi: 10.1097/QAD.0000000000004145.
PMID: 39912762